Patents by Inventor Edward P. Cohen

Edward P. Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of identifying tumor associated antigens
    Patent number: 9186418
    Abstract: Compositions and methods of producing improved cancer vaccines are described. In addition, methods of identifying tumor associated antigens are also described.
    Type: Grant
    Filed: December 13, 2011
    Date of Patent: November 17, 2015
    Assignee: The Board of Trustees of the University of Illinois
    Inventor: Edward P. Cohen
  • Cancer Vaccines and Therapeutic Methods
    Publication number: 20120164180
    Abstract: Compositions and methods of producing improved cancer vaccines are described. In addition, methods of identifying tumor associated antigens are also described.
    Type: Application
    Filed: December 13, 2011
    Publication date: June 28, 2012
    Applicant: The Board of Trustees of the University of Illinois
    Inventor: Edward P. Cohen
  • Therapeutic Cancer Antigens
    Publication number: 20110014241
    Abstract: The present invention relates to cells, pharmaceutical compositions, tumor vaccines, kits and methods for inhibiting cell proliferation or tumor growth in a mammal, specifically, the invention relates to cells that express a tumor-associated tumor antigen.
    Type: Application
    Filed: March 13, 2009
    Publication date: January 20, 2011
    Applicant: The Board of Trustees of the Unversity Illinois
    Inventor: Edward P. Cohen
  • Cancer immunotherapy with semi-allogeneic cells
    Patent number: 7670611
    Abstract: The present invention relates to improved semi-allogeneic immunogenic cells which act to stimulate and induce an immunological response when administered to an individual. In particular, it relates to cells which express both allogeneic and syngeneic MHC determinants and which also express at least one antigen recognized by T lymphocytes. The invention is also directed to methods of inducing an immune response and methods of treating tumors by administering the semi-allogeneic immunogenic cells to an individual.
    Type: Grant
    Filed: May 6, 2008
    Date of Patent: March 2, 2010
    Assignee: The Board of Trustees of the University of Illinois
    Inventor: Edward P. Cohen
  • Cancer Vaccines and Therapeutic Methods
    Publication number: 20090214494
    Abstract: Compositions and methods of producing improved cancer vaccines are described. In addition, methods of identifying tumor associated antigens are also described.
    Type: Application
    Filed: March 28, 2006
    Publication date: August 27, 2009
    Applicant: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOI
    Inventor: Edward P. Cohen
  • Cancer Immunotherapy with Semi-Allogeneic Cells
    Publication number: 20080305131
    Abstract: The present invention relates to improved semi-allogeneic immunogenic cells which act to stimulate and induce an immunological response when administered to an individual. In particular, it relates to cells which express both allogeneic and syngeneic MHC determinants and which also express at least one antigen recognized by T lymphocytes. The invention is also directed to methods of inducing an immune response and methods of treating tumors by administering the semi-allogeneic immunogenic cells to an individual.
    Type: Application
    Filed: May 6, 2008
    Publication date: December 11, 2008
    Applicant: The Board of Trustees of the University of Illinois
    Inventor: Edward P. Cohen
  • Cancer immunotherapy with semi-allogeneic cells
    Patent number: 7402306
    Abstract: The present invention relates to improved semi-allogeneic immunogenic cells which act to stimulate and induce an immunological response when administered to an individual. In particular, it relates to cells which express both allogeneic and syngeneic MHC determinants and which also express at least one antigen recognized by T lymphocytes. The invention is also directed to methods of inducing an immune response and methods of treating tumors by administering the semi-allogeneic immunogenic cells to an individual.
    Type: Grant
    Filed: March 10, 2000
    Date of Patent: July 22, 2008
    Assignee: The Board of Trustees of the University of Illinois
    Inventor: Edward P. Cohen
  • Cancer immunotherapy with semi-allogeneic cells
    Patent number: 6187307
    Abstract: The present invention relates to improved semi-allogeneic immunogenic cells which act to stimulate and induce an immunological response when administered to an individual. In particular, it relates to cells which express both allogeneic and syngeneic MHC determinants and which also express at least one antigen recognized by T lymphocytes. The invention is also directed to methods of inducing an immune response and methods of treating tumors by administering the semi-allogeneic immunogenic cells to an individual.
    Type: Grant
    Filed: January 30, 1998
    Date of Patent: February 13, 2001
    Assignee: Research Corporation Technologies, Inc.
    Inventor: Edward P. Cohen
  • Immunotherapeutic strategies for the treatment of cancer
    Patent number: 5759535
    Abstract: The present invention is directed to a method for the treatment of neoplastic disease comprising administering to a mammal having a tumor a cellular immunogen comprising an allogeneic population of cells expressing S one or more cytoldnes and tumor associated antigens encoded by autologous genomic tumor DNA.
    Type: Grant
    Filed: May 13, 1994
    Date of Patent: June 2, 1998
    Assignee: Research Corporation Technologies, Inc.
    Inventor: Edward P. Cohen